M. Lorraine Gibbins
About M. Lorraine Gibbins
M. Lorraine Gibbins is the Director of Clinical Safety and Pharmacovigilance at Adaptimmune, where she has worked since 2019. She has extensive experience in pharmacovigilance and clinical safety, having held various roles at notable companies including Merck, MedImmune, Shire, and Johnson & Johnson.
Current Role at Adaptimmune
M. Lorraine Gibbins serves as the Director of Clinical Safety & Pharmacovigilance at Adaptimmune. She has held this position since 2019, contributing to the company's focus on patient safety and risk management in clinical trials. Her role involves overseeing pharmacovigilance activities and ensuring compliance with regulatory requirements in the Greater Philadelphia Area.
Previous Experience in Pharmacovigilance
Prior to her current role, Gibbins worked at several notable pharmaceutical companies. She was a Clinical Risk Management Scientist at Merck from 2011 to 2012 and a Pharmacovigilance Scientist at MedImmune from 2014 to 2017. Additionally, she held positions at Shire, where she was an Aggregate Safety Reporting Lead and later a Global Safety Scientist from 2017 to 2019.
Education and Expertise
Gibbins studied Nursing at Drexel University and obtained her degree from Hahnemann University School of Allied Health Professions. She also attended St. Joseph's College, where she achieved a degree in Health Management. Her expertise includes developing Risk Management Plans (RMPs) and Drug Risk Management Plans (DRMPs), as well as creating Standard Operating Procedures (SOPs) for pharmacovigilance.
Background in Clinical Nursing
M. Lorraine Gibbins has a background in clinical nursing, with experience as a supervisor in critical care and emergency/trauma settings. This clinical experience has informed her work in pharmacovigilance and patient safety. Additionally, she has worked as a legal nurse consultant in the pharmaceutical and biotech/medical device industries.
Vendor Oversight and Process Development
Gibbins has experience in vendor oversight related to safety systems in pharmacovigilance. Her role has involved process development, ensuring that safety protocols and reporting mechanisms are effective and compliant with industry standards. This experience enhances her contributions to clinical safety and pharmacovigilance at Adaptimmune.